International Oncology is working relentlessly towards making sure that cancer is detected earlier, thereby increasing the chances of survival. Of the more noteworthy projects that International Oncology has embarked on pilot studies which have actually received the support of the International Finance Corporation. The details of the studies are as under.
Enhanced Visual Assessment (EVA) System by MobileODT: The Enhanced Visual Assessment (EVA) System by MobileODT is a smartphone-based integrated cervical cancer screening and patient tracking system, that enables health professionals with different levels of training to conduct digital cervicography in cervical cancer screening, follow-up, and monitoring. The EVA System has already been used successfully in over 21 countries in the world in several projects such as HPV screening in El Salvador, Point of Pap Colposcopy in Mexico, training and supervision for VIA in Ethiopia, to name a few.
One of the major challenges facing International Oncology when providing care to women in India who are at risk of cervical cancer is the loss to follow up care among patients who screen positive on primary cervical cancer screening tests. This leads to high rates of disease progression and mortality from cervical cancer in India. Today, International Oncology is conducting Pap exams and is experiencing high rates of loss to follow up- women with abnormal Paps are often not seeking secondary screening or treatment. International Oncology will test the integration of the EVA System into its cervical cancer screening programs in three (3) of its affiliated hospitals and thirteen (13) outreach centers run by those hospitals, in a structured pilot that will seek to demonstrate a cost effective intervention that addresses loss-to-follow-up, which is a key pain point in cervical cancer screening in India.
The EVA System can address the challenges of the cervical cancer screening programs run by International Oncology by enabling point-of-care visualization of the cervix, image capture for digital cervicography, patient data capture, and connecting point-of-care providers to experts remotely via cloud for expert case review. In doing so, the EVA System can reduce loss-to-follow-up using the EVA System’s patient tracking system and integrated electronic medical records that facilitate on-going engagement with the patient. The reporting occurs automatically via SIM card connectivity, while the screenings are taking place. In using the EVA System, International Oncology will be able to reduce loss to follow-up, thereby saving more lives, as well as generating more revenue for the health system from the associated increase in therapeutic procedures.
Adoption of Zilico Zedscan in improving the speed and treatment outcomes for HG-CIN
Zilico has devised the Evaluation Protocol Single Arm (EPSA) and has implemented its usage in a number of different countries for the enhancement of the speed and accuracy of colposcopic examination for diagnosis of Cancer of the cervix. The optimized workflow using the Zedscan demonstrates a higher degree of sensitivity, specificity, PPV and NPV (100%, 52.1%, 55.8%, 97.8%) that have been achieved in previous studies.
The study outcomes will be to demonstrate the Zedscan’s role in :
- Reduction in the time for the detection of HG-CIN (High Grade – Cervical Intraepithilial Neoplasia) in women referred to colposcopy and improve the efficiency of the clinical pathway thus providing enhanced clinical outcomes.
- Optimizing the costs to the healthcare service provider by optimizing the number of biopsies being taken and the time to provide a confirmatory diagnosis.
- Provide a platform and a workflow for a “see and treat” protocol.
- An overall improvement in the patient experience.